On April 23, 2025, the U.S. Food and Drug Administration (FDA) granted approval to Akeso Biopharma Co., Ltd.’s penpulimab-kcqx for the first-line treatment of adults with recurrent or metastatic ...

In his Truth Social post, President Trump also addressed the issue of Fentanyl entering the U.S. from China via Mexico and ...

Investing.com -- B. Riley downgraded ON Semiconductor (NASDAQ: ON) to “Neutral” from “Buy” and cut its price target to $41 ...

Investing.com -- While Federal Reserve Chairman Jerome Powell has insisted on a wait-and-see approach to additional interest ...

Investing.com -- Shares of Soligenix (NASDAQ: SNGX) climbed 2.9% following the company’s announcement of promising results for its skin cancer treatment, HyBryteTM, in treating cutaneous T-cell ...

“Small businesses are feeling the pinch,” said Simon Gaudreault, CFIB’s chief economist. “The raging trade war will likely ...

Pony.ai’s latest autonomous driving system boasts a 100% automotive-grade ADK, a significant 70% reduction in BOM costs, and a modular platform architecture for easy adaptation across different ...

On Thursday, cloud storage company Backblaze (NASDAQ: BLZE) saw its shares plummet 8.3% following a scathing short report from Morpheus Research. The report detailed a series of alleged financial ...

Waller expressed a strong belief that tariffs are a one-time price effect, suggesting that businesses may be frozen as a result of these trade measures. He further indicated that it wouldn’t surprise ...

"Prices are still up by more than 25% so far this year, supported by market volatility and ever-changing U.S. policies. The ...

Under the deal, Autodesk (NASDAQ: ADSK) will add Jeff Epstein and Christie Simons to its Board of Directors. Both appointees ...

“Apple’s launch of an AI-enabled Siri has been delayed and can cause a further pushout of iPhones upgrades,” analysts wrote.